Rootpath Revenue and Competitors
Estimated Revenue & Valuation
- Rootpath's estimated annual revenue is currently $930k per year.
- Rootpath's estimated revenue per employee is $155,000
Employee Data
- Rootpath has 6 Employees.
- Rootpath grew their employee count by -33% last year.
Rootpath's People
Name | Title | Email/Phone |
---|
Rootpath Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is Rootpath?
RootPath, Inc. is a Cambridge, MA-based early-stage biotechnology company focusing on next-generation immuno- and cell-therapy. At RootPath, we leverage our proprietary and patent-pending single-cell analysis and manipulation technologies to functionally decipher anti-tumor immunity, and to create next-generation personalized and 'off-the-shelf' T cell therapies that have the potential to offer significant improvement over existing approaches.
keywords:N/AN/A
Total Funding
6
Number of Employees
$930k
Revenue (est)
-33%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Rootpath News
RootPath is a synthetic biology company that elevates the throughput of gene function interrogation by orders of magnitude.
The cornerstone of RootPath's technology suite is PathFinder DNA Assembly, a Molecular Programming-based technology, which enables autonomous...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.4M | 6 | 0% | N/A |
#2 | $0.4M | 6 | 0% | N/A |
#3 | $0.9M | 6 | 20% | N/A |
#4 | $0.7M | 7 | 0% | N/A |
#5 | $1.1M | 7 | 0% | N/A |